These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25490867)

  • 1. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
    Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
    Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry work-up.
    Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
    Cytometry B Clin Cytom; 2014 Oct; ():. PubMed ID: 25336233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.
    Wangen JR; Eidenschink Brodersen L; Stolk TT; Wells DA; Loken MR
    Int J Lab Hematol; 2014 Apr; 36(2):184-96. PubMed ID: 24118926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
    Malcovati L; Della Porta MG; Lunghi M; Pascutto C; Vanelli L; Travaglino E; Maffioli M; Bernasconi P; Lazzarino M; Invernizzi R; Cazzola M
    Leukemia; 2005 May; 19(5):776-83. PubMed ID: 15789068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
    Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
    Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
    Della Porta MG; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
    Leukemia; 2006 Apr; 20(4):549-55. PubMed ID: 16498394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
    Westers TM; Cremers EM; Oelschlaegel U; Johansson U; Bettelheim P; Matarraz S; Orfao A; Moshaver B; Brodersen LE; Loken MR; Wells DA; Subirá D; Cullen M; Te Marvelde JG; van der Velden VH; Preijers FW; Chu SC; Feuillard J; Guérin E; Psarra K; Porwit A; Saft L; Ireland R; Milne T; Béné MC; Witte BI; Della Porta MG; Kern W; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):308-319. PubMed ID: 27758818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
    Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
    Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
    Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
    Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
    Li J; He GS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
    Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
    Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
    Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
    Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
    Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
    Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.